Renk DR, Skraban M, Bier D, Schulze A, Wabbals E, Wedekind F, Neumaier F, Neumaier B, Holschbach M (2021). “Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A2A receptor ligands.” Eur J Med Chem 214: 113214
Bier D, Holschbach M, Wedekind F, Sihver W, Drewes B, Schulze A, Neumaier F, Neumaier B, Bauer A (2020). “Preparation of 5-[131I]iodotubercidin for the detection of adenosine kinase.” J Radioanal Nucl Chem. 326
He X, Wedekind F, Kroll T, Oskamp A, Beer S, Drzezga A, Ermert J, Neumaier B, Bauer A, Elmenhorst D (2020). “Image-Derived Input Functions for Quantification of A1 Adenosine Receptors Availability in Mice Brains Using PET and [18F]CPFPX.” Front Physiol.
Wedekind F, Oskamp A, Lang M, Hawlitschka A, Zilles K, Wree A, Bauer A (2018). “Intrastriatal administration of botulinum neurotoxin A normalizes striatal D2 R binding and reduces striatal D1 R binding in male hemiparkinsonian rats.” J Neurosci Res. 96
Oskamp A, Wedekind F, Kroll T, Elmenhorst D, Bauer A (2017). “Neurotransmitter receptor availability in the rat brain is constant in a 24 hour-period.” Chronobiol Int. 34(7): 866-875
Elmenhorst D, Mertens K, Kroll T, Oskamp A, Ermert J, Elmenhorst EM, Wedekind F, Beer S, Coenen HH, Bauer A (2016). “Circadian variation of metabotropic glutamate receptor 5 availability in the rat brain.” J Sleep Res. 25(6): 754-761
Ingwersen J, Wingerath B, Graf J, Lepka K, Hofrichter M, Schröter F, Wedekind F, Bauer A, Schrader J, Hartung HP, Prozorovski T, Aktas O (2016). “Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.” J Neuroinflammation 13(48)
Kim Y, Elmenhorst D, Weisshaupt A, Wedekind F, Kroll T, McCarley RW, Strecker RE, Bauer A (2015). “Chronic sleep restriction induces long-lasting changes in adenosine and noradrenaline receptor density in the rat brain.” J Sleep Res. 24(5): 549-558
Kroll T, Elmenhorst D, Matusch A, Celik AA, Wedekind F, Weisshaupt A, Beer S, Bauer A (2014). “[18F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT2A receptor densities in the rat brain.” Nucl Med Biol. 41(1): 1-9
Elmenhorst D, Kroll T, Wedekind F, Weisshaupt A, Beer S, Bauer A (2013). “In vivo kinetic and steady-state quantification of 18F-CPFPX binding to rat cerebral A1 adenosine receptors: validation by displacement and autoradiographic experiments.” J Nucl Med. 54(8): 1411-9
Kroll T, Elmenhorst D, Matusch A, Wedekind F, Weisshaupt A, Beer S, Bauer A (2013). “Suitability of [18F]altanserin and PET to determine 5-HT2A receptor availability in the rat brain: in vivo and in vitro validation of invasive and non-invasive kinetic models.” Mol Imaging Biol. 15(4): 456-67
Riegert C, Wedekind F, Hamida SB, Rutz S, Rothmaier AK, Jones BC, Cassel JC, Jackisch R (2008). “Effects of ethanol and 3,4-methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain.” Int J Neuropsychopharmacol. 11(6): 743-63
Berger B, Rothmaier AK, Wedekind F, Zentner J, Feuerstein TJ, Jackisch R (2006). “Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.” Br J Pharmacol. 148(6): 795-806